A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Profound Medical Corp. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 760,457 shares of PROF stock, worth $5.85 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
760,457
Previous 681,562 11.58%
Holding current value
$5.85 Million
Previous $5.72 Million 5.86%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$7.47 - $11.18 $589,345 - $882,046
78,895 Added 11.58%
760,457 $6.05 Million
Q2 2024

Jul 19, 2024

BUY
$7.25 - $9.07 $406,703 - $508,799
56,097 Added 8.97%
681,562 $5.72 Million
Q1 2024

Apr 22, 2024

BUY
$7.3 - $9.46 $21,264 - $27,556
2,913 Added 0.47%
625,465 $5.34 Million
Q4 2023

Jan 16, 2024

BUY
$7.85 - $11.18 $563,983 - $803,227
71,845 Added 13.05%
622,552 $5.29 Million
Q3 2023

Oct 24, 2023

SELL
$7.91 - $13.27 $241,484 - $405,119
-30,529 Reduced 5.25%
550,707 $5.62 Million
Q2 2023

Jul 25, 2023

BUY
$9.27 - $14.88 $635,300 - $1.02 Million
68,533 Added 13.37%
581,236 $7.56 Million
Q1 2023

Apr 14, 2023

BUY
$8.85 - $13.27 $1.72 Million - $2.59 Million
194,893 Added 61.32%
512,703 $4.76 Million
Q4 2022

Feb 08, 2023

BUY
$3.18 - $10.91 $893,045 - $3.06 Million
280,832 Added 759.46%
317,810 $3.46 Million
Q3 2022

Oct 25, 2022

SELL
$3.99 - $9.3 $1,065 - $2,483
-267 Reduced 0.72%
36,978 $149,000
Q2 2022

Aug 12, 2022

SELL
$6.34 - $9.53 $61,282 - $92,116
-9,666 Reduced 20.6%
37,245 $272,000
Q1 2022

May 11, 2022

BUY
$8.16 - $11.33 $67,581 - $93,835
8,282 Added 21.44%
46,911 $422,000
Q4 2021

Feb 08, 2022

SELL
$10.38 - $15.2 $348,622 - $510,507
-33,586 Reduced 46.51%
38,629 $436,000
Q3 2021

Nov 02, 2021

BUY
$13.6 - $17.88 $163,920 - $215,507
12,053 Added 20.03%
72,215 $1.05 Million
Q2 2021

Aug 11, 2021

SELL
$16.0 - $20.59 $3,104 - $3,994
-194 Reduced 0.32%
60,162 $980,000
Q1 2021

May 14, 2021

BUY
$19.16 - $28.09 $65,144 - $95,506
3,400 Added 5.97%
60,356 $1.21 Million
Q4 2020

Feb 12, 2021

BUY
$16.4 - $22.9 $233,831 - $326,508
14,258 Added 33.39%
56,956 $1.17 Million
Q3 2020

Nov 04, 2020

BUY
$14.05 - $18.13 $440,678 - $568,647
31,365 Added 276.76%
42,698 $751,000
Q2 2020

Jul 17, 2020

SELL
$9.41 - $16.94 $37,856 - $68,149
-4,023 Reduced 26.2%
11,333 $192,000
Q1 2020

Apr 21, 2020

BUY
$6.88 - $19.7 $105,649 - $302,513
15,356 New
15,356 $148,000

Others Institutions Holding PROF

About Profound Medical Corp.


  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $160M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.